🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

SARS-CoV-2 receptor networks in diabetic and COVID-19–associated kidney disease

Kidney International(2020)10.1016/j.kint.2020.09.015Source: DataRank Database

SARS-CoV-2 receptor networks in diabetic and COVID-19–associated kidney disease is a research paper published in Kidney International (2020). On theSindex it has a DataRank of 2.2. It has been cited 91 times, with 64 citing works in its 1-hop citation network.

N/A

2.2DataRank · unranked

Scored on demand from live citation data

Open Access91 citations · 64 citing works in its network

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (57 grants)Impact (FWCI 1.81)OA: hybridTopics (66)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 31%Citation Network 69%

Base Score Contribution

0.678

From this paper's citation signal

Citation Network Contribution

1.5

From 48 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 64 citers.

Sodium-glucose co-transporter 2 inhibitors in COVID-19: meeting at the crossroads between heart, diabetes and infectious diseases
International Journal of Clinical Pharmacy202134 citations21 referencesContributes 0.169
Urinary Single-Cell Profiling Captures the Cellular Diversity of the Kidney
Journal of the American Society of Nephrology2021112 citations37 referencesContributes 0.128
Clinical Characteristics of COVID-19 Patients in a Regional Population With Diabetes Mellitus: The ACCREDIT Study
Frontiers in Endocrinology202212 citations26 referencesContributes 0.099
Impact of COVID-19 on Kidney of Diabetic Patients
Medicina20228 citations27 referencesContributes 0.081
Associations of microvascular complications with all‐cause death in patients with diabetes and COVID ‐19: The CORONADO , ABCD COVID‐19 UK national audit and AMERICADO study groups
Diabetes Obesity and Metabolism20226 citations25 referencesContributes 0.078

Authors (32)

Edgar A. Otto ORCID,Rachel Sealfon ORCID,Viji Nair ORCID,Aaron K. Wong ORCID,Chandra L. Theesfeld ORCID

Live enrichment

PubMed:33038424 PMC:PMC7543950 OpenAlex:https://openalex.org/W3092165380

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: DK020572

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: DK069062

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: DK092926

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: DK083912

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: P30 DK081943

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: UH3DK114923

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: UH3DK114908

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: UH3DK114861

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: UH3DK114915

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: UH3DK114870

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: UH3DK114933

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: UH3DK114920

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: UH3DK114937

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: UH3DK114926

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: UH3DK114866

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: DK082841

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: U2C DK114886

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: UH3DK114907

NIDDK NIH HHS

Grant: U54 DK083912

NIDDK NIH HHS

Grant: T32 DK007378

NCATS NIH HHS

Grant: UL1 TR002240

NIDDK NIH HHS

Grant: R24 DK082841

NIDDK NIH HHS

Grant: U24 DK114886

NIDDK NIH HHS

Grant: P30 DK020572

NIDDK NIH HHS

Grant: P30 DK092926

NIDDK NIH HHS

Grant: P60 DK020572

NIDDK NIH HHS

Grant: U01 DK114907

Intramural NIH HHS

Grant: Z01 DK069062

National Institutes of Health

Grant: 4UH3DK114908-03

Cleveland Precision Medicine Chronic Kidney Disease Cohort

National Institutes of Health

Grant: 3UH3DK114920-04S2

Nicotinamide Riboside for AKI in COVID-19 positive inpatients

National Institutes of Health

Grant: 2P30DK081943-06

Administrative Core

National Institutes of Health

Grant: 4UH3DK114870-03

Chronic Kidney Disease Precision Medicine Project

National Institutes of Health

Grant: 1R24DK082841-01

Integrated Systems Biology Approach to Diabetic Microvascular Complications

National Institutes of Health

Grant: 1U2CDK114886-01

Central Hub for Kidney Precision Medicine

National Institutes of Health

Grant: 5UH3DK114866-05

AKI Matched Phenotype Linked Evaluation with Tissue (AMPLE-Tissue)

National Institutes of Health

Grant: 5UH3DK114937-05

Multidimensional cellular interrogation of the kidney in AKI and CKD

National Institutes of Health

Grant: 4UH3DK114926-03

Kidney Precision Medicine Program (KPMP): Columbia AKI Recruitment Site

National Institutes of Health

Grant: 3UH3DK114907-03S1

PREcision Medicine through IntErrogation of Rna in the kidnEy (PREMIERE)

National Institutes of Health

Grant: 4UH3DK114923-03

Nephron Sub-segmental Omics and Quantitative 3D Imaging of Human Kidney.

National Institutes of Health

Grant: 5UH3DK114861-04

Phenotyping REnal Cases In Sepsis and surgery for Early Acute Kidney Injury (PReCISE AKI)

National Institutes of Health

Grant: 3UH3DK114933-03S1

Single-nucleus sequencing and in situ mapping of mRNA molecules in human kidney

National Institutes of Health

Grant: 5UH3DK114915-05

Harvard Chronic Kidney Disease Research Biopsy Center

National Institutes of Health

Grant: 1ZIADK069062-23

Epidemiology, Pathophysiology and Treatment of Diabetic Nephropathy

University of Washington

Broad Institute

University of California, San Diego

European Molecular Biology Laboratory

Indiana University

Stanford University

Chan Zuckerberg Initiative

Juvenile Diabetes Research Foundation United States of America

amfAR, The Foundation for AIDS Research

National Institutes of Health

University of Pittsburgh

Ohio State University

Yale University

University of Michigan

FWCI

1.81

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.kint.2020.09.015

publisherhttps://doi.org/10.1016/j.kint.2020.09.015

publisherhttps://api.elsevier.com/content/article/PII:S0085253820311133?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0085253820311133?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33038424

Fields of Study

COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19COVID-19 and healthcare impacts0301 basic medicine03 medical and health sciences0303 health sciences

MeSH Terms

Angiotensin-Converting Enzyme 2COVID-19SARS-CoV-2AdultAgedAngiotensin-Converting Enzyme InhibitorsDiabetic NephropathiesFemaleHumansKidney Tubules, ProximalMaleMiddle AgedCase-Control StudiesGene Expression ProfilingGene Regulatory NetworksHost-Pathogen InteractionsAngiotensin Receptor Antagonists

Keywords

Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakMedicineBetacoronavirusVirologyDiseaseKidney diseaseCoronavirus InfectionsCoronavirusPandemicInternal medicineInfectious disease (medical specialty)OutbreakDiabetic nephropathyAcute Kidney InjuryAce InhibitorsMolecular NetworksProximal TubulesScrnaseqCovid-19Sars-cov-2AdultMale570610Angiotensin-Converting Enzyme InhibitorsKidney Tubules, ProximalAngiotensin Receptor AntagonistsHumansDiabetic NephropathiesGene Regulatory NetworksAgedGene Expression ProfilingProximalMiddle AgedKidney TubulesBasic ResearchNephrologyCase-Control StudiesHost-Pathogen InteractionsFemaleAngiotensin-Converting Enzyme 2

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Related Papers (5)

Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract

N/A

6.1DataRank · unranked

EBioMedicine(2020)

co-cited

10.1016/j.ebiom.2020.102976

Clinical Characteristics of Hospitalized Covid-19 Patients in New York City

Top 4%

5.4DataRank

medRxiv(2020)

co-cited

10.1101/2020.04.19.20062117

Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics

N/A

8.2DataRank · unranked

Nature Medicine(2021)

co-cited

10.1038/s41591-020-01227-z

Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions

N/A

6.5DataRank · unranked

Nature Communications(2021)

co-cited

10.1038/s41467-021-21361-7

Inhibition of HECT E3 ligases as potential therapy for COVID-19

N/A

1.5DataRank · unranked

Cell Death and Disease(2021)

co-cited

10.1038/s41419-021-03513-1